Loading....
WEBINAR DESCRIPTION
In this webinar, Dr. Jan Bewersdorf will discuss the latest research presented at EHA and ASCO on MDS and AML. This is an advanced presentation. There will be a Q & A session and questions can be submitted in advance to help@aamds.org.
Thank you to our 2025 Sponsors.
Diamond Level
Silver Level
Bronze Level
WEBINAR FACULTY
Dr. Jan Philipp Bewersdorf is an Assistant Professor of Medicine (Hematology) at Yale University. Following medical school training in Germany, he completed his Internal Medicine training at Yale - New Haven Hospital. After completion of residency, Dr. Bewersdorf pursued his fellowship in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center in New York before joining the faculty at Yale in July 2024. Dr. Bewersdorf is board-certified in Internal Medicine, Medical Oncology and Hematology.
His career as a clinician-scientist has been dedicated to myeloid malignancies spanning from myeloproliferative neoplasms to myelodysplastic syndromes and acute myeloid leukemia. Dr. Bewersdorf's work aims to combine basic and translational research with clinical and outcomes research to study those disorders from multiple angles. Inspired by the privilege of taking care of patients with myeloid neoplasms, he strives to advance patient care by conducting innovative clinical trials with a strong correlative component in collaboration with laboratory-based colleagues.
Thank you for registering for this webinar.
You will receive an email with a registration confirmation including the webinar link
and a call-in phone # for those participating via telephone.
If you do not receive the link, please check your Spam/Junk folders.
If you have not received a registration confirmation, please email clark@aamds.org
or call (800) 747-2820 x2 no later than 30 minutes before the webinar is scheduled to begin.
If you are not able to join the webinar, an archived video will be available in 7-10 business days on the AAMDSIF website.